EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

Also called NCT06762145

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06762145
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06762145. Randomized; single masking; primary purpose prevention. Start 2025-01-01 (anticipated); primary completion 2025-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial)
Acronym
EAGLE-TAVR
Condition
Transcatheter Aortic Valve Replacemen
Condition
Left Bundle Branch Block
Intervention (Drug)
Methylprednisolone (Corticosteroid)
Intervention (Drug)
Placebo
Lead sponsor
Xiao-dong Zhuang (class: other)

Record details

Record id
cardio:ct-nct06762145
Content hash
8997ba531c0a13eeb3be63cc6cab9b51868c392e77ad3a4ff08acca727c45d62